Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fitell Corporation Announces Updated Registered Direct Offering for up to $10.0 Million
-
Palisade Bio Presents Positive Preclinical Data of PALI-2108 for the Treatment of Ulcerative Colitis
-
MultiCorp International, Inc.
-
Invesco Ltd: Form 8.3 -American Axle & Manufacturing Holdings Inc; Public dealing disclosure
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
DynaResource to Present at the Metals and Mining Growth Virtual Investor Conference February 13, 2025 at 12:00 pm ET
-
Viva Gold to Present at the Metals and Mining Growth Virtual Investor Conference February 12th
-
Q2 Metals to Present at the Metals and Mining Growth Virtual Investor Conference February 12th
-
Amerigo Resources to Present at the Metals and Mining Growth Virtual Investor Conference February 13th
-
DatChat to Debut Its New Myseum Forever Digital Shoebox Platform at RootsTech 2025
-
SWVL Announces $2 Million Private Placement Priced At-the-Market Under Nasdaq Rules
-
Liquidity Services Announces New Partnership with Core by Biocom California to Help Life Science Companies Maximize the Value of Their Assets
-
BioCryst to Present New ORLADEYO® (berotralstat) Results from APeX-P Pediatric Trial at 2025 American Academy of Allergy, Asthma & Immunology / World Allergy Organization Joint Congress
-
The RealReal Reports Strong Preliminary Fourth Quarter and Full Year 2024 Results; Projects Profitable Growth for 2025; Completes Strategic Debt Exchange Strengthening its Financial Position
-
Annual Volcon CEO Update
-
Paradigm Oil and Gas Partners with Hallmark Venture Group to Drive Scalable Revenue Growth
-
Achieve Life Sciences Announces Positive Outcome of Second Data Safety Monitoring Committee Review for the ORCA-OL Clinical Trial
-
Dillard’s Introduces Kristin Ellen Hockman for Edgehill
-
Locus Technologies Earns Two EBJ Business Achievement Awards
-
Oncocyte Prices $29.1 Million Equity Offering
-
Australian Oilseeds Announces First Quarter Fiscal 2025 Financial Results
-
Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
-
Inspired Entertainment Announces Long-Term Contract Extension with Moto Hospitality
-
Varonis Announces $100 Million Share Repurchase Authorization
-
GEN Korean BBQ Expands Footprint in Texas with New Location in San Antonio
-
Aspo Plc will publish its Financial Statements Release for year 2024 on February 17, 2025
-
Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis
-
Velcan Holdings: Share buyback program - weekly statement
-
Kvika banki hf.: Correction: Publication of annual financial statements on Wednesday 12 February
-
Ocean Power Technologies Announces Demonstration of WAM-V at NAVDEX
-
KFSHRC Detects 276 Fetal Genetic Disorders Through Prenatal Care Saving SAR 360 Million Annually
-
Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience
-
Hill International Signs MOU with the State Agency for Restoration and Infrastructure Development of Ukraine
-
Grace Therapeutics Announces Private Placement Financing of up to $30 Million
-
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
-
IMUNON Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer
-
Boehringer’s nerandomilast meets primary endpoint in Phase III study FIBRONEER™-ILD, in progressive pulmonary fibrosis
-
Nasdaq, Inc. Announces Cash Tender Offers for Up to $200 Million Outstanding Debt Securities
-
Qu Biologics’ Immunomodulator Clears Senescence
-
Grace Therapeutics Announces Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH
-
We’re (SUPER) Sorry for your Team’s Loss: Vivid Seats and The Bouqs Co. Launch Consolation Contest
-
Ashvattha Presents Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025 Conference
-
Jasper Therapeutics Announces Briquilimab Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting
-
FlexShopper Provides Business Update for January 2025
-
Mustang Bio Announces Closing of $8 Million Public Offering
-
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy
-
Wärtsilä introduces next-generation engine to balance renewables and improve power plant performance
-
New Clinical Trial Data Highlights RAD 101 (18F-Pivalate) Successfully Detects Brain Metastases
-
Vera Bradley Continues Board Refreshment with Appointment of Andrew Meslow, Former CEO of Bath and Body Works
-
Palvella Therapeutics to Expand Phase 3 SELVA Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations to Include the You
